Products

A completely new category of lenses that utilize a clear lens’ inherent chromatic aberration in a positive way to increase retinal dopamine which then directly and indirectly results in a thicker choroid and a stronger sclera. Both of which increase the strength of the eye’s ocular structure thus offsetting part or all of the force causing axial elongation.  DopaLens™ can also be worn by patients with other types of dopamine deficiency disorders.

(QT for Quick Time) A darkened, enhanced version of DopaLens™ that is worn for brief periods of time independent of one’s conventional myopic correcting eyewear or as fit over eyewear in addition one’s conventional eyewear. DopaQT™ delivers only the specific wavelengths of light required to produce dopamine in the eye’s retina.  For this reason, DopaQT™ should be able to be worn for minutes in the morning and mid-day to slowdown, and possibly stop myopia progression. DopaQT™ can also be worn by patients with other types of dopamine deficiency disorders.

The use of blue light (within the wavelength range of 475nm +/- 20nm) to increase retinal dopamine which then directly and indirectly results in a thicker choroid and a stronger sclera. Both of which increase the strength of the eye’s ocular structure thus offsetting part or all of the force causing axial elongation.  DopaTherapy™ can be employed prior to a child becoming myopic or after becoming myopia. DopaTherapy™ can also be employed for helping other types of dopamine disorders.

Eyewear used to deliver DopaTherapy™ for enhancing the production of Dopamine in the Eye.